Observations placeholder

Thalomid and Thalidomide

Identifier

015752

Type of Spiritual Experience

Hallucination

Number of hallucinations: 65

Background

A description of the experience

Thalidomide currently sold as Immunoprin, Talidex, Talizer, or Thalomid,  is an immunomodulatory drug and the prototype of the thalidomide class of drugs.

Today, thalidomide is sold as a treatment of certain cancers (multiple myeloma) and of a complication of leprosy.

Thalidomide was first marketed in 1957 in West Germany under the trade-name Contergan. The German drug company Chemie Grünenthal (now Grünenthal) developed and sold the drug. Primarily prescribed as a sedative or hypnotic, thalidomide also claimed to cure “anxiety, insomnia, gastritis, and tension". Afterwards, it was used against nausea and to alleviate morning sickness in pregnant women. Thalidomide became an over the counter drug in Germany on October 1, 1957. Shortly after the drug was sold in Germany, between 5,000 and 7,000 infants were born with phocomelia (malformation of the limbs). Only 40% of these children survived. Throughout the world, about 10,000 cases were reported of infants with phocomelia due to thalidomide; only 50% of the 10,000 survived. Those subjected to thalidomide while in the womb experienced limb deficiencies in a way that the long limbs either were not developed or presented themselves as stumps. Other effects included deformed eyes and hearts, deformed alimentary and urinary tracts, blindness and deafness. The negative effects of thalidomide led to the development of more structured drug regulations and control over drug use and development.

Leprosy also known as Hansen's disease (HD), is a chronic infection caused by the bacteria Mycobacterium leprae and Mycobacterium lepromatosis.

On Mar, 7, 2015: 26,630 people reported to have side effects when taking Thalomid. Among them, 8,852 people (33.24%) have Death.

Time on Thalomid when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 24.77% 45.10% 14.28% 10.59% 4.92% 0.34% 0.00%

Gender of people who have Death when taking Thalomid  :

  Female Male
Death 36.96% 63.04%

Age of people who have Death when taking Thalomid  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Death 0.05% 0.37% 0.43% 0.66% 2.17% 6.87% 16.67% 72.78%

 

On Mar, 29, 2015: 26,631 people reported to have side effects when taking Thalomid. Among them, 65 people (0.24%) have Hallucination.

Time on Thalomid when people have Hallucination  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Hallucination 27.59% 44.83% 24.14% 3.45% 0.00% 0.00% 0.00%

 

 

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

References